150 related articles for article (PubMed ID: 25266970)
1. Evaluation of the reproducibility of the Naranjo Adverse Drug Reaction Probability Scale score in published case reports.
Liang R; Borgundvaag B; McIntyre M; Thwaites C; Ragan K; Wyllie A
Pharmacotherapy; 2014 Nov; 34(11):1159-66. PubMed ID: 25266970
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury.
García-Cortés M; Lucena MI; Pachkoria K; Borraz Y; Hidalgo R; Andrade RJ;
Aliment Pharmacol Ther; 2008 May; 27(9):780-9. PubMed ID: 18284654
[TBL] [Abstract][Full Text] [Related]
3. Comparison of WHO-UMC and Naranjo Scales for Causality Assessment of Reported Adverse Drug Reactions.
Pandit S; Soni D; Krishnamurthy B; Belhekar MN
J Patient Saf; 2024 Jun; 20(4):236-239. PubMed ID: 38345209
[TBL] [Abstract][Full Text] [Related]
4. Are the Naranjo criteria reliable and valid for determination of adverse drug reactions in the intensive care unit?
Kane-Gill SL; Kirisci L; Pathak DS
Ann Pharmacother; 2005 Nov; 39(11):1823-7. PubMed ID: 16204392
[TBL] [Abstract][Full Text] [Related]
5. The Functional Movement Screen: a reliability study.
Teyhen DS; Shaffer SW; Lorenson CL; Halfpap JP; Donofry DF; Walker MJ; Dugan JL; Childs JD
J Orthop Sports Phys Ther; 2012 Jun; 42(6):530-40. PubMed ID: 22585621
[TBL] [Abstract][Full Text] [Related]
6. Interrater agreement of two adverse drug reaction causality assessment methods: A randomised comparison of the Liverpool Adverse Drug Reaction Causality Assessment Tool and the World Health Organization-Uppsala Monitoring Centre system.
Mouton JP; Mehta U; Rossiter DP; Maartens G; Cohen K
PLoS One; 2017; 12(2):e0172830. PubMed ID: 28235001
[TBL] [Abstract][Full Text] [Related]
7. Accuracy and reproducibility of two scales in causality assessment of unexpected hepatotoxicity.
Miljkovic MM; Dobric S; Dragojevic-Simic V
J Clin Pharm Ther; 2012 Apr; 37(2):196-203. PubMed ID: 21718339
[TBL] [Abstract][Full Text] [Related]
8. Comparison of two recently published algorithms for assessing the probability of adverse drug reactions.
Busto U; Naranjo CA; Sellers EM
Br J Clin Pharmacol; 1982 Feb; 13(2):223-7. PubMed ID: 7059419
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Internet Social Networks using Net scoring Tool: A Case Study in Adverse Drug Reaction Mining.
Katsahian S; Simond Moreau E; Leprovost D; Lardon J; Bousquet C; Kerdelhué G; Abdellaoui R; Texier N; Burgun A; Boussadi A; Faviez C
Stud Health Technol Inform; 2015; 210():526-30. PubMed ID: 25991203
[TBL] [Abstract][Full Text] [Related]
10. A quantitative approach of using genetic algorithm in designing a probability scoring system of an adverse drug reaction assessment system.
Koh Y; Yap CW; Li SC
Int J Med Inform; 2008 Jun; 77(6):421-30. PubMed ID: 17921048
[TBL] [Abstract][Full Text] [Related]
11. Quality of case reports of adverse drug reactions with psychotropic drugs: a 25-year review.
Talat B; Mayers A; Baldwin DS
Hum Psychopharmacol; 2013 Sep; 28(5):413-20. PubMed ID: 23754771
[TBL] [Abstract][Full Text] [Related]
12. A review and assessment of drug-induced parotitis.
Brooks KG; Thompson DF
Ann Pharmacother; 2012 Dec; 46(12):1688-99. PubMed ID: 23249870
[TBL] [Abstract][Full Text] [Related]
13. A targeted method for standardized assessment of adverse drug events in surgical patients.
de Boer M; Kiewiet JJ; Boeker EB; Ramrattan MA; Dijkgraaf MG; Lie-A-Huen L; Boermeester MA;
J Eval Clin Pract; 2013 Dec; 19(6):1073-82. PubMed ID: 23593984
[TBL] [Abstract][Full Text] [Related]
14. Agreement between WHO-UMC causality scale and the Naranjo algorithm for causality assessment of adverse drug reactions.
Shukla AK; Jhaj R; Misra S; Ahmed SN; Nanda M; Chaudhary D
J Family Med Prim Care; 2021 Sep; 10(9):3303-3308. PubMed ID: 34760748
[TBL] [Abstract][Full Text] [Related]
15. Development of the Liverpool Adverse Drug Reaction Avoidability Assessment Tool.
Bracken LE; Nunn AJ; Kirkham JJ; Peak M; Arnott J; Smyth RL; Pirmohamed M; Turner MA
PLoS One; 2017; 12(1):e0169393. PubMed ID: 28046035
[TBL] [Abstract][Full Text] [Related]
16. Agreement of expert judgment in causality assessment of adverse drug reactions.
Arimone Y; Bégaud B; Miremont-Salamé G; Fourrier-Réglat A; Moore N; Molimard M; Haramburu F
Eur J Clin Pharmacol; 2005 May; 61(3):169-73. PubMed ID: 15827761
[TBL] [Abstract][Full Text] [Related]
17. MOdified NARanjo Causality Scale for ICSRs (MONARCSi): A Decision Support Tool for Safety Scientists.
Comfort S; Dorrell D; Meireis S; Fine J
Drug Saf; 2018 Nov; 41(11):1073-1085. PubMed ID: 29876835
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the Bayesian approach and a simple algorithm for assessment of adverse drug events.
Lanctôt KL; Naranjo CA
Clin Pharmacol Ther; 1995 Dec; 58(6):692-8. PubMed ID: 8529335
[TBL] [Abstract][Full Text] [Related]
19. Reliability and reproducibility of subaxial cervical injury description system: a standardized nomenclature schema.
Bono CM; Schoenfeld A; Gupta G; Harrop JS; Anderson P; Patel AA; Dimar J; Aarabi B; Dailey A; Vaccaro AR; Gahr R; Shaffrey C; Anderson DG; Rampersaud R
Spine (Phila Pa 1976); 2011 Aug; 36(17):E1140-4. PubMed ID: 21587109
[TBL] [Abstract][Full Text] [Related]
20. Quality evaluation of JAMA Patient Pages on diabetes using the Ensuring Quality Information for Patient (EQIP) tool.
Vaona A; Marcon A; Rava M; Buzzetti R; Sartori M; Abbinante C; Moser A; Seddaiu A; Prontera M; Quaglio A; Pallazzoni P; Sartori V; Rigon G
Prim Care Diabetes; 2011 Dec; 5(4):257-63. PubMed ID: 21917537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
